ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY - ANVISA Registration 80867150119
Access comprehensive regulatory information for ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80867150119 and manufactured by SHENZHEN YHLO BIOTECH CO., LTD.. The registration is held by BIOMOLECULAR TECHNOLOGY COMÉRCIO, IMPORTAÇÃO, EXPORTAÇÃO E DISTRIBUIÇÃO DE MATERIAIS MÉDICOS E LABORATORIAIS LTDA - EPP with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including MEDIPAN, RSR LIMITED, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80867150119
25351824440202139
07767477000146
Company Information
Dates and Status
Aug 05, 2021
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTI-DESCARBOXILASE DE ÁCIDO GLUTÂMICO (GAD)
Família MAGLUMI Anti-GAD (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512904
Nov 21, 2022
ANTICORPO ANTI-DESCARBOXILASE DE ÁCIDO GLUTÂMICO (GAD)
GADA CONTROL
SHENZHEN YHLO BIOTECH CO., LTD
80867150137
Oct 20, 2022
ANTICORPO ANTI-DESCARBOXILASE DE ÁCIDO GLUTÂMICO (GAD)
Medizym® anti-GAD M
MEDIPAN
80464810723
Oct 29, 2020
ANTICORPO ANTI-DESCARBOXILASE DE ÁCIDO GLUTÂMICO (GAD)
GAD
BIOMERICA
10300390485
May 20, 2019
ANTICORPO ANTI-DESCARBOXILASE DE ÁCIDO GLUTÂMICO (GAD)
anti GAD ELISA
MEDIPAN
80836930039
May 26, 2014

